Teleflex (TFX) said Thursday it has been awarded a contract to supply its Central Venous Access Catheters and Arterial Catheters to Vizient, a healthcare performance improvement company in the US.
The agreement is effective Jan. 1, the company said. It said Vizient provider-customers will now gain access to increased savings and pre-negotiated terms on Teleflex's vascular access products through the agreement.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.